Increased expression of enolase α in human breast cancer confers tamoxifen resistance in human breast cancer cells
Loss of CSMD1 expression is associated with high tumour grade and poor survival in invasive ductal breast carcinoma
A prospective study of variability in mammographic density during the menstrual cycle
An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers
Targeting glucosylceramide synthase downregulates expression of the multidrug resistance gene MDR1 and sensitizes breast carcinoma cells to anticancer drugs
Breast cancer cells can switch between estrogen receptor α and ErbB signaling and combined treatment against both signaling pathways postpones development of resistance
High levels of uPA and PAI-1 predict a good response to anthracyclines
High levels of uPA and PAI-1 predict a good response to anthracyclines
Immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
Discussion: immediate post-mastectomy breast reconstruction followed by radiotherapy: risk factors for complications
The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2 -associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers
Metabolic profile, physical activity, and mortality in breast cancer patients
Serum insulin-like growth factor (IGF)-1 and IGF binding protein-3 in relation to breast cancer among Hispanic and white, non-Hispanic women in the US Southwest
Evaluation of breast cancer service screening programme with a Bayesian approach: mortality analysis in a Finnish region
Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years
Gene promoter methylation is associated with increased mortality among women with breast cancer
A genetic variant in the pre-miR-27a oncogene is associated with a reduced familial breast cancer risk
Glutathione S-transferase M1 polymorphism and breast cancer susceptibility: a meta-analysis involving 46,281 subjects
Impact of multiple caregiving roles on elevated depressed mood in early-stage breast cancer patients and same-age controls
Lack of association between catechol- O -methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls
Expression of TGF-β signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics
Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Influence of birthplace on breast cancer diagnosis and treatment for Hispanic women
Density of tumour stroma is correlated to outcome after adoptive transfer of CD4+ and CD8+ T cells in a murine mammary carcinoma model
Two-stage case-control study of DNMT-1 and DNMT-3B gene variants and breast cancer risk
Reliable data on 5- and 10-year survival provide accurate estimates of 15-year survival in estrogen receptor-positive early-stage breast cancer
Overexpression of p53 is correlated with poor outcome in premenopausal women with breast cancer treated with tamoxifen after chemotherapy
Severe prolonged cholestatic hepatitis caused by exemestane
Tamoxifen sensitivity and estrogen receptor mRNA levels
Correlation between consanguineous marriages and age-standardized mortality rate due to breast cancer, an ecologic study
Sustained lower rates of breast cancer incidence in France in 2007